S 5471 (see companion bill A 236) – New York
Introduced: 2017 Status: Inactive / Dead
REQUIRES THE COMMISSIONER OF HEALTH TO ESTABLISH AND PUBLISH A LIST OF GENERIC DRUG PRODUCTS: The commissioner shall establish and publish a list of drug products matched to brand name drugs with which they have …
S 706 (see companion bill H 1133) – Massachusetts
Introduced: 2019 Status: Inactive / Dead
For legislation to ensure prescription drug cost transparency and affordability. Health Care Financing.
S 715 – Massachusetts
Introduced: 2019 Status: Inactive / Dead
For legislation relative to pharmaceutical price transparency and cost sharing. Health Care Financing.
S 728 – Massachusetts
Introduced: 2019 Status: Inactive / Dead
For legislation to provide affordable access to generic medicines . Health Care Financing.
S 749 (see companion bill H 945) – Massachusetts
Introduced: 2023 Status: In Process
An Act to ensure prescription drug cost transparency and affordability
S 771 (see companion bill H 1279) – Massachusetts
Introduced: 2021 Status: Inactive / Dead
For legislation relative to pharmaceutical access, costs and transparency. The assessed amount for pharmaceutical and biopharmaceutical manufacturing companies and pharmacy benefit managers shall be not less than 25 per cent of the amount appropriated by …
S 778 – Massachusetts
Introduced: 2023 Status: In Process
An Act to bring down the cost of prescription drugs. Notwithstanding any general or special law to the contrary, the health policy commission shall conduct a study examining the feasibility of establishing a program for …
S 7837 (see companion bill A 8838) – New York
Introduced: 2022 Status: In Process
Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy …
S 786 (replaced by S 771) – Massachusetts
Introduced: 2021 Status: Inactive / Dead
For legislation to bring down the cost of prescription drugs. Notwithstanding any general or special law to the contrary, the health policy commission shall conduct a study examining the feasibility of establishing a program for …
S 797 – Massachusetts
Introduced: 2023 Status: In Process
An Act to bring down the cost of prescription drugs. Notwithstanding any general or special law to the contrary, the health policy commission shall conduct a study examining the feasibility of establishing a program for …
S 92 – Vermont
Introduced: 2018 Status: Enacted Year Enacted: 2018
Requires pharmacists to dispense the lowest priced generic or interchangeable product. Would require an insurer to annually file a summary of proposed rates, including an analysis of the impact of drug cost on premium increases. …
S 98 – Vermont
Introduced: 2023 Status: In Process
This bill proposes to authorize and direct the Green Mountain Care Board to evaluate the costs of certain high-cost prescription drugs and recommend methods for addressing those costs, including setting limits on what Vermonters would …
SB 0169 – Maryland
Introduced: 2018 Status: Inactive / Dead
ESTABLISHING A PRESCRIPTION DRUG AND MEDICAL SUPPLY ACCESS AND AFFORDABILITY WORKGROUP: requires the Secretary of Health to convene a workgroup to study the advisability of the State forming a generic drugs and medical supplies purchasing cooperative …
SB 100 (see companion bill AB 114) – Wisconsin
Introduced: 2019 Status: Inactive / Dead
Registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. The bill requires pharmacy benefit managers to provide a reasonably adequate and accessible network of pharmacies. The bill …
SB 1021 – California
Introduced: 2018 Status: Enacted Year Enacted: 2018
Prescription Drugs: Existing law prohibits the formulary or formularies for outpatient prescription drugs maintained by a health care service plan or health insurer from discouraging the enrollment of individuals with health conditions and from reducing …
SB 103 (see companion bill HB 276) – Georgia
Introduced: 2017 Status: Enacted
RELATING TO THE REGULATION AND LICENSURE OF PHARMACY BENEFIT MANAGERS: authorizes the Commissioner of Insurance to promulgate rules and regulations to prohibit PBMs from requiring the use of mail-order pharmacies. Would ban the PBM practice …